$3.10
-0.01 (-0.32%)
Open$3.12
Previous Close$3.11
Day High$3.25
Day Low$3.08
52W High$11.68
52W Low$2.90
Volume—
Avg Volume10.9K
Market Cap35.25M
P/E Ratio—
EPS$-0.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,013.2% upside
Current
$3.10
$3.10
Target
$34.51
$34.51
$26.32
$34.51 avg
$56.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.98M | 2.00M | 21.69M |
| Net Income | -8,013,959 | -7,262,675 | 2.61M |
| Profit Margin | -404.1% | -383.9% | 12.0% |
| EBITDA | -7,910,809 | -7,567,484 | 4.63M |
| Free Cash Flow | — | — | 2.95M |
| Rev Growth | -0.7% | -0.7% | +19.5% |
| Debt/Equity | 0.02 | 0.02 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |